Unitedhealth Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Unitedhealth's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Unitedhealth in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
543.16544.90546.64
Details
Intrinsic
Valuation
LowReal ValueHigh
528.81530.55598.07
Details
Naive
Forecast
LowNext ValueHigh
553.22554.95556.69
Details
21 Analysts
Consensus
LowTarget PriceHigh
440.00503.54575.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Unitedhealth. Your research has to be compared to or analyzed against Unitedhealth's peers to derive any actionable benefits. When done correctly, Unitedhealth's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Unitedhealth Group.

Unitedhealth Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Unitedhealth and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Unitedhealth and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Unitedhealth Group does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Unitedhealth Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Unitedhealth stock performing well and Unitedhealth company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Unitedhealth's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
A 1.80  0.14  0.08  0.18  1.89  0.07 (2.03)  4.22 (3.15)  8.98 
ABEO 5.15  0.31  0.05  0.37  5.85  0.0442 (5.53)  12.02 (8.99)  32.82 
CVX 1.75 (0.04) (0.02)  0.02  2.34 (0.0222) (1.68)  3.06 (4.35)  11.62 
TRV 1.23 (0.05) (0.05)  0.00  1.58 (0.0475) (1.28)  2.28 (2.33)  9.03 
MMM 1.08  0.00 (0.02)  0.07  1.38 (0.0161) (1.11)  2.50 (2.13)  6.70 
JPM 1.45 (0.02) (0.01)  0.05  1.52 (0.0055) (1.78)  3.03 (2.34)  10.79 
JNJ 0.83 (0.13)  0.00 (0.23)  0.00 (0.16)  0.00  1.75 (2.01)  5.07 
AXP 1.77 (0.05) (0.01)  0.04  2.24 (0.0059) (1.83)  3.79 (3.84)  9.74 
XOM 1.94  0.14  0.05  0.23  2.59  0.05 (1.86)  3.33 (3.96)  10.43 

Cross Equities Net Income Analysis

Select Fundamental

2010201120122013201420152016201720182019202020212022
AB1.2 B734 M549 M401 M462 M684 M316 M1.1 B719 M719 M647.1 M639.6 M
ABEO(10.5 M)(10.5 M)(10.5 M)4.4 M(26.8 M)(14.5 M)(21.9 M)(27.3 M)(56.7 M)(76.3 M)(84.2 M)(84.9 M)(87.2 M)
CVX26.9 B26.9 B26.2 B21.4 B19.2 B4.6 B(497 M)9.2 B14.8 B2.9 B(5.5 B)15.6 B13.4 B
TRV3.2 B1.4 B2.5 B3.7 B3.7 B3.4 BB2.1 B2.5 B2.6 B2.7 B3.7 B3.1 B
MMM4.3 B4.3 B4.4 B4.7 BB4.8 BB4.9 B5.3 B4.5 B5.4 B5.9 BB
JPM17.6 B17.6 B19.9 B16.6 B20.1 B22.7 B22.8 B22.6 B30.7 B34.6 B27.4 B46.5 B39.3 B
JNJ9.7 B9.7 B16.5 B16.5 B16.5 B16.5 B16.5 B1.3 B20.9 B20.9 B20.9 B20.9 B11.7 B
AXP4.9 B4.9 B4.5 B5.4 B5.9 B5.2 B5.4 B2.7 B6.9 B6.8 B3.1 B8.1 B7.3 B
XOM30.5 B41.1 B44.9 B32.6 B32.5 B16.1 B7.8 B19.7 B20.8 B14.3 B(22.4 B)23 B24.7 B

Unitedhealth Group and related stocks such as Agilent Technologies, Abeona Therapeutics, Chevron Corp, The Travelers Companies, 3M Company, JP Morgan Chase, Johnson Johnson, American Express, and Exxon Mobil Corp Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Unitedhealth Group financial statement analysis. It represents the amount of money remaining after all of Unitedhealth Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Unitedhealth Competitive Analysis

The better you understand Unitedhealth competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Unitedhealth's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Unitedhealth's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
UNHAABEOCVXTRVMMMJPMJNJAXPXOM
 0.31 
 545.39 
Unitedhealth
 1.21 
 133.55 
Agilent
 0.90 
 4.47 
Abeona
 1.84 
 156.91 
Chevron
 0.0117 
 171.54 
Travelers
 0.81 
 151.00 
3M
 0.33 
 121.73 
JP Morgan
 0.29 
 165.78 
Johnson
 0.31 
 165.33 
American
 1.93 
 92.19 
Exxon
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Unitedhealth Competition Performance Charts

Complement your Unitedhealth position

In addition to having Unitedhealth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Also, please take a look at Unitedhealth Correlation with its peers. Note that the Unitedhealth Group information on this page should be used as a complementary analysis to other Unitedhealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Unitedhealth Stock analysis

When running Unitedhealth Group price analysis, check to measure Unitedhealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unitedhealth is operating at the current time. Most of Unitedhealth's value examination focuses on studying past and present price action to predict the probability of Unitedhealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Unitedhealth's price. Additionally, you may evaluate how the addition of Unitedhealth to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Unitedhealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unitedhealth. If investors know Unitedhealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unitedhealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Unitedhealth Group is measured differently than its book value, which is the value of Unitedhealth that is recorded on the company's balance sheet. Investors also form their own opinion of Unitedhealth's value that differs from its market value or its book value, called intrinsic value, which is Unitedhealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unitedhealth's market value can be influenced by many factors that don't directly affect Unitedhealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unitedhealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Unitedhealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unitedhealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
UNH
 Stock
  

USD 545.39  1.69  0.31%   

Unitedhealth Group competes with Agilent Technologies, Abeona Therapeutics, Chevron Corp, Travelers Companies, and 3M; as well as few others. The company runs under Healthcare sector within Healthcare Plans industry. Analyzing Unitedhealth competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Unitedhealth to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Unitedhealth competition on your existing holdings. Also, please take a look at Unitedhealth Correlation with its peers.
  
Unitedhealth Return on Sales is most likely to increase slightly in the upcoming years. The last year's value of Return on Sales was reported at 0.08. Unitedhealth Assets Non Current are most likely to increase significantly in the upcoming years. The last year's value of Assets Non Current was reported at 80.04 Billion. The current Goodwill and Intangible Assets is estimated to increase to about 54.5 B, while Tax Assets are projected to decrease to roughly 447.4 M.